Startup Brellium built an artificial-intelligence-powered solution that helps providers automate clinical quality and payer ...

Veeva Systems is overvalued, with modest ~10% growth & high valuation multiples. Read why I recommend a sell rating on VEEV ...

Bristol-Myers Squibb is undervalued with a 5%+ dividend yield, robust pipeline, and recession-resistant business. Click here ...

BayCare Health System recently finalized its $4 billion disaffiliation from Trinity Health, ushering in what executives are calling “BayCare 2.0” — a new era of local governance, strategic agility and ...

Humanity has always searched for answers to its greatest dilemmas—questions that science, medicine, and psychology often ...

At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health ...

Market OverviewThe Global Nanomedicine Market is valued at USD 273.79 Billion in 2024 and is projected to reach a value of ...

Novavax's COVID-19 vaccine showed fewer side effects than Pfizer's in a Utah study as FDA seeks more data before full ...

In today’s healthcare landscape, “survival” isn’t just a dramatic turn of phrase — for many hospital and health system CFOs, it’s an honest reflection of the stakes. Mounting reimbursement uncertainty ...

Qure's AMT-130 receives FDA Breakthrough Therapy designation for Huntington's disease, adding to Fast Track, RMAT, and Orphan ...

Discover the top 3 undervalued Diversified Consumer Services stocks for Wednesday, April 23 based on AAII’s Stock Grades.